Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linagliptin monotherapy for arterial stiffness in early type 2 diabetes
NL-OMON40278Phase 3Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Linagliptin + lifestyle advice with Placebo + lifestyle advice (2 arms). Primary endpoint: Mean pulse wave velocity. Started Feb 2014; status: active, not recruiting.
02
Drugs
linagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON40278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40278.